These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9037558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk.
    Wu X, Hsu TC, Cao S, Lee JJ, Amos CI, Spitz MR.
    Carcinogenesis; 1998 Jan; 19(1):93-8. PubMed ID: 9472699
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan.
    Lin P, Wang HJ, Lee H, Lee HS, Wang SL, Hsueh YM, Tsai KJ, Chen CY.
    J Toxicol Environ Health A; 1999 Oct 29; 58(4):187-97. PubMed ID: 10591487
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations.
    Wu X, Amos CI, Kemp BL, Shi H, Jiang H, Wan Y, Spitz MR.
    Cancer Epidemiol Biomarkers Prev; 1998 Jan 29; 7(1):13-8. PubMed ID: 9456237
    [Abstract] [Full Text] [Related]

  • 9. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States).
    Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK.
    Cancer Causes Control; 1997 Jul 29; 8(4):554-9. PubMed ID: 9242470
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
    Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT.
    Blood; 1999 Jul 15; 94(2):803-7. PubMed ID: 10397748
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking.
    Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH.
    Pharmacogenetics; 1995 Aug 15; 5(4):199-206. PubMed ID: 8528266
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans.
    Strom SS, Wu S, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez J, Tee PG, Spitz MR.
    J Natl Cancer Inst Monogr; 1995 Aug 15; (18):29-33. PubMed ID: 8562219
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
    London SJ, Daly AK, Cooper J, Carpenter CL, Navidi WC, Ding L, Idle JR.
    Pharmacogenetics; 1996 Apr 15; 6(2):151-8. PubMed ID: 9156693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.